When putting together your watch list, focus on stocks with an 80 or higher RS Rating. Artivion just met that criteria with a new score of 82.
Looking For The Best Stocks To Buy And Watch? Start Here
This proprietary rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
History reveals that the top-performing stocks tend to have an RS Rating of over 80 in the early stages of their moves.
Artivion is now considered extended and out of buy range after clearing a 29.73 buy point in a first-stage cup with handle. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings growth increased last quarter from -91% to 0%. But sales fell from 4% to 2%. The next quarterly results are expected on or around Aug. 7.
The company holds the No. 22 rank among its peers in the Medical-Products industry group. Hinge Health, Boston Scientific and Insulet are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
